The investment firm Morningstar has announced that it will now pick drug stocks based upon each company’s vulnerability to poor reviews of their prices by the Institute for Clinical and Read more
Tag: Biology
Bio-Rad and German-based biotech Qiagen weighing latest tie-up in medical-diagnostic market
Bio-Rad Laboratories Inc. is in talks to combine with fellow life-sciences company Qiagen NV in a deal that would be worth more than $10 billion, according to people familiar with the matter. The talks Read more
Investors piling into health-care ETFs points to defensive bets, ‘bottom-fishing’ in biotech
Hello! In this week’s ETF Wrap, health-care ETFs take the spotlight as investors get defensive amid recession fears. But inflows also show that some investors may be “bottom-fishing” for beaten Read more